PodParley PodParley
PodParley
They Sold Their Company to Boston Scientific and Then Reacquired the Technology Years Later – The Unique Story of NuCryo Vascular episode artwork

EPISODE · Feb 26, 2016 · 44 MIN

They Sold Their Company to Boston Scientific and Then Reacquired the Technology Years Later – The Unique Story of NuCryo Vascular

from Medsider: Learn from Medtech and Healthtech Founders and CEOs · host Scott Nelson

Because of diminishing margins, a lot of major medical device companies continue to add products to their sales bag in hopes of meeting top-line revenue goals. But selling the entire bag is challenging. When the bag gets too big, a typical sales force ...

Episode metadata supplied by the publisher feed · Published Feb 26, 2016

Embed this episode

Ready to play

They Sold Their Company to Boston Scientific and Then Reacquired the Technology Years Later – The Unique Story of NuCryo Vascular

0:00 44:18

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medsider: Learn from Medtech and Healthtech Founders and CEOs?

This episode is 44 minutes long.

When was this Medsider: Learn from Medtech and Healthtech Founders and CEOs episode published?

This episode was published on February 26, 2016.

Can I download this Medsider: Learn from Medtech and Healthtech Founders and CEOs episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!